Philips Clinical & Medical Affairs Global
Clinical trials sponsored by Philips Clinical & Medical Affairs Global, explained in plain language.
-
Could a Week-Long heart patch catch more dangerous rhythms than a One-Day test?
Diagnosis TerminatedThis study tested whether wearing a small, waterproof heart monitor (ePatch) for 7 days finds more treatable heart rhythm problems than the usual 24-hour Holter monitor in people who have fainted. About 55 adults with fainting symptoms were randomly assigned to either the 7-day e…
Phase: NA • Sponsor: Philips Clinical & Medical Affairs Global • Aim: Diagnosis
Last updated Jun 27, 2026 08:02 UTC
-
New blood flow test for leg artery disease shows promise in small study
Knowledge-focused TerminatedThis study tested a new, non-invasive way to measure blood flow in the legs of people with peripheral artery disease (PAD). Researchers compared the new method to standard ultrasound in 29 patients scheduled for a procedure to open blocked leg arteries. The goal was to see if the…
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Oxygen sensor study halted early – what it means for patient monitoring
Knowledge-focused TerminatedThis study tested how accurately Philips SpO2 sensors measure blood oxygen levels in 24 healthy adults aged 18-50. The sensors were compared to standard lab tests during rest. The study was terminated early, so the full results are not available.
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC